US regulator makes 2 observations at Neuland Labs’ facility Industry-The Economic Times — April 8, 2017 comments off “The USFDA inspected Unit 1, manufacturing facility at Bonthapally, Hyderabad of the company from April 3-7, 2017. At the end of the inspection, there were 2 observations given under form 483,” Neuland Laboratories said.
